---
title: "Loteprednol Etabonate - Iridocyclitis"
sidebar: mydoc_sidebar
permalink: db14596-mesh-d015863-1.html
toc: false 
---


Path ID: `DB14596_MESH_D015863_1`
{% include image.html url="images/db14596-mesh-d015863-1.png" file="db14596-mesh-d015863-1.png" alt="db14596-mesh-d015863-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069559 | Loteprednol etabonate | Drug |
| UniProt:P04150 | Glucocorticoid receptor | Protein |
| UniProt:P04083 | Annexin A1 | Protein |
| UniProt:P47712 | Cytosolic phospholipase A2 | Protein |
| UniProt:P35354 | Prostaglandin G/H synthase 2 | Protein |
| MESH:D011453 | Prostaglandins | ChemicalSubstance |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D015863 | Iridocyclitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Loteprednol Etabonate | INCREASES ACTIVITY OF | Glucocorticoid Receptor |
| Glucocorticoid Receptor | INCREASES ACTIVITY OF | Annexin A1 |
| Annexin A1 | DECREASES ACTIVITY OF | Cytosolic Phospholipase A2 |
| Annexin A1 | NEGATIVELY REGULATES | Prostaglandin G/H Synthase 2 |
| Cytosolic Phospholipase A2 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandin G/H Synthase 2 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandins | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Iridocyclitis |
|---------|-----------|---------|

Comment: Please note that original DrugBank ID was DB00873 for drug loteprednol, however the loteprednol etabonate has been annotated in DrugBank under DB14596.

Reference: 
  - [https://pubmed.ncbi.nlm.nih.gov/19104500/](https://pubmed.ncbi.nlm.nih.gov/19104500/)
  - [https://go.drugbank.com/drugs/DB14596](https://go.drugbank.com/drugs/DB14596)
